Fredun Pharmaceuticals (BOM:539730) COGS-to-Revenue : 0.78 (As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Fredun Pharmaceuticals COGS-to-Revenue?

Fredun Pharmaceuticals's Cost of Goods Sold for the three months ended in Jun. 2024 was ₹608 Mil. Its Revenue for the three months ended in Jun. 2024 was ₹775 Mil.

Fredun Pharmaceuticals's COGS to Revenue for the three months ended in Jun. 2024 was 0.78.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Fredun Pharmaceuticals's Gross Margin % for the three months ended in Jun. 2024 was 21.54%.

Fredun Pharmaceuticals COGS-to-Revenue Historical Data

The historical data trend for Fredun Pharmaceuticals's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fredun Pharmaceuticals COGS-to-Revenue Chart

Fredun Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

COGS-to-Revenue

Get a 7-Day Free Trial

0.77

0.81

0.83

0.80

0.79

Fredun Pharmaceuticals Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
COGS-to-Revenue	Get a 7-Day Free Trial															0.78	0.81	0.77	0.80	0.78

Fredun Pharmaceuticals COGS-to-Revenue Calculation

Fredun Pharmaceuticals's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	2749.402	/	3465.769
	=	0.79

Fredun Pharmaceuticals's COGS to Revenue for the quarter that ended in Jun. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	608.335	/	775.358
	=	0.78

Fredun Pharmaceuticals (BOM:539730) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Fredun Pharmaceuticals's Gross Margin % for the three months ended in Jun. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	608.335 / 775.358
	=	21.54 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Fredun Pharmaceuticals COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Fredun Pharmaceuticals's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Fredun Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fredun Pharmaceuticals Ltd (BOM:539730) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

Ganpatrao Kadam Marg, 11th Floor, Urmi Estate, Lower Parel (West), Mumbai, MH, IND, 400013

Website

http://www.fredungroup.com

Fredun Pharmaceuticals Ltd is an India based company engaged in the business of pharmaceuticals and healthcare. The company manufactures pharmaceutical formulations, nutraceuticals, herbal supplements, and dietary supplements. In addition, it also manufactures animal healthcare products through its group companies. It sells its products in India and also exports its formulations as branded generics to international countries.

Fredun Pharmaceuticals Headlines

No Headlines